Deep Dive
1. Token Unlock Schedule (Bearish Impact)
Overview: Monthly unlocks of 16.23 million LAB are scheduled from August to December 2026, with a significant portion of supply marked “Untracked” and potentially unlocking anytime. These events directly increase circulating supply, historically triggering sell-offs as early investors and team members liquidate holdings. For example, a delayed public-sale unlock in August 2026 contributed to a 99.94% crash from all-time highs.
What this means: Each unlock event acts as a predictable supply shock, likely suppressing price rallies in the short to medium term. Until the unlock schedule is fully absorbed or transparently managed, upside will be capped by constant sell-pressure from insiders and early backers.
Overview: LAB is a multi-chain trading terminal with AI research and execution tools, supporting networks like TON, Solana, and Base. Recent updates include BSC Flip Mode, Boost Mode presets, and MoonPay fiat on-ramps. The team claims over $12M in cumulative fees and 22.68M LAB bought back, though these figures are unverified.
What this means: Genuine user growth and fee generation could create organic demand for the token, especially if staking or reward programs gain traction. Successful integration of high-performance chains like Monad may attract sophisticated traders, providing a fundamental basis for price recovery if adoption metrics improve.
3. Insider Control & Market Manipulation Risks (Bearish Impact)
Overview: On-chain investigators like ZachXBT allege that over 95% of LAB’s supply is controlled by insiders and market makers, who have orchestrated pump-and-dump schemes via coordinated exchange activity. Whales have moved millions of tokens to hot wallets before large dumps, eroding trust.
What this means: Until the team demonstrates transparent tokenomics and distances itself from manipulation allegations, LAB will struggle to attract institutional or long-term holders. Any price pump remains vulnerable to sudden insider selling, making sustained appreciation unlikely without a clear governance overhaul.
Conclusion
LAB’s path is bifurcated: product improvements offer a narrow route to recovery, while unlock schedules and trust deficits present steep hurdles. For holders, the key is monitoring whether user growth can outpace insider selling.
Will the next unlock be met with sustained buying or another sharp decline?